Mark W. Grinstaff
- B.A., Occidental College, 1987
- Ph.D., University of Illinois at Urbana-Champaign, 1992
- National Academy of Inventors Charter Fellow, 2012
- Kern Faculty Fellow, 2012
- Stevenson Biomaterials Lecturer, Syracuse Biomaterials Institute, Syracuse University, 2011
- Boston University Innovator of the Year, 2010
- Elected to the College of Fellows of the American Institute for Medical and Biomedical Engineering (AIMBE), 2010
- Professeur Invité and Certificat sur Honneur, Université de Bordeaux (Bordeaux II), 2010
- COE Distinguished Faculty Fellow (5-year Endowed Fellowship), 2009
- Edward M. Kennedy Award for Health Care Innovation, 2008
- Professeurr Invité and Certificat sur Honneur, Université de la Maditerranée (Aix-Marseille II), 2007
- Elected Fellow of the American Academy of Nanomedicine, 2006
- Johnson and Johnson Focused Giving Grant Recipient, 2001
- 3M Non-Tenured Faculty Award, 2001
- Alfred P. Sloan Research Fellowship, 2000
- Camille Dreyfus Teacher-Scholar, 2000
- Pew Scholar in the Biomedical Sciences, 1999
- NSF Career Award, 1999
- Whitaker Foundation Grant Recipient, 1998
- ACS Nobel Laureate Signature Award, 1994
- NIH Postdoctoral Fellowship, 1993
- T.S. Piper Award for Outstanding Inorganic Research, 1991
- The ACS Fellowship of the Colloid & Surface Division (Sponsored by Procter & Gamble), 1990
- University of Illinois Chemistry Department Fellowship, 1989
The Grinstaff Group pursues highly interdisciplinary research in the areas of biological and macromolecular chemistry. The major goal in these research projects is to elucidate the underlying fundamental chemistry and engineering principles and to use that insight to direct our creative and scientific efforts.
- We are designing, synthesizing, and characterizing novel dendrimers, termed “biodendrimers,” for tissue engineering and biotechnological applications. Currently, we are evaluating these novel biomaterials for the repair of corneal lacerations, for the delivery of anti-cancer drugs, for the delivery of DNA, and as temporary biodegradable scaffolds for cartilage repair.
- We are creating novel polymeric coatings termed “interfacial biomaterials” that control biology on plastic, metal, and ceramic surfaces.
- We are designing electrochemical-based sensors/devices using conducting polymer nanostructures and specific DNA structural motifs.